G1 (ISOFORM A) Adhesion G-Protein-Coupled Receptor: A Potential Drug Target and Biomarker

Target Name: Adhesion G-protein coupled receptor G1 (isoform a)

NCBI ID: P2233

Adhesion G-protein coupled receptor G1 (isoform a)

G1 (ISOFORM A) Adhesion G-Protein-Coupled Receptor: A Potential Drug Target and Biomarker

Introduction

G-protein-coupled receptors (GPCRs) are a family of transmembrane proteins that play a crucial role in cellular signaling. GPCRs are involved in various physiological processes, including sensory perception, neurotransmission, and hormone signaling. The G1 (ISOFORM A) adhesion G -protein-coupled receptor is a GPCR that is expressed in various tissues and cells, including the brain, heart, and gastrointestinal tract. This receptor is involved in cell-cell and cell-tissue adhesion, which is critical for various physiological processes, including tissue repair, inflammation, and development.

G1 Receptor: Structure and Function

The G1 (ISOFORM A) adhesion G-protein-coupled receptor is a seven transmembrane helix receptor that consists of an extracellular domain, a transmembrane region, and an intracellular domain. The transmembrane region consists of four alpha helices, which are responsible for the stability and integrity of the channel. The receptor has a unique fold, which is characterized by a long N-terminal region that contains a leucine-rich repeat (LRR), a proline-rich region, and a short C-terminal region that contains a G-protein-coupled receptor (GPCR) domain.

The G1 receptor is involved in cell-cell and cell-tissue adhesion. Adhesion is the process by which cells stick together to form tissues and organs. The G1 receptor is involved in the formation of tight junctions, which are specialized barriers that separate epithelial cells and form tissues. The G1 receptor is also involved in the formation ofdesmosomes, which are protein-rich structures that are involved in cell-cell adhesion.

G1 Receptor Signaling

The G1 (ISOFORM A) adhesion G-protein-coupled receptor is involved in various signaling pathways. One of the well-known signaling pathways involves the TGF-β pathway. TGF-β is a cytokine that plays a crucial role in cell growth, differentiation, and inflammation. The G1 receptor is involved in the regulation of TGF-β signaling by the protein SMAD (stimulated-mediated acquisition of DNA).

The G1 receptor has been shown to be a potential drug target in various diseases, including cancer, neurodegenerative diseases, and autoimmune diseases. For example, studies have shown that inhibition of the G1 receptor can lead to increased cancer cell migration and invasion. In neurodegenerative diseases, G1 receptor has been shown to be involved in the regulation of neurotransmission and the maintenance of neural stem cells. In autoimmune diseases, G1 receptor has been shown to be involved in the regulation of immune cell function.

G1 Receptor Targets

The G1 (ISOFORM A) adhesion G-protein-coupled receptor is a potential drug target due to its involvement in various signaling pathways. One of the primary targets of the G1 receptor is the protein SMAD, which is a transcription factor that plays a crucial role in the regulation of gene expression. The SMAD complex consists of the proteins SMAD1 and SMAD2, which are involved in the regulation of cell growth, differentiation, and inflammation.

Another target of the G1 receptor is the protein PDZP2, which is a protein that is involved in the regulation of the formation of tight junctions. The PDZP2 protein is a negative regulator of the G1 receptor, and its inhibition has been shown to

Protein Name: Adhesion G-protein Coupled Receptor G1 (isoform A)

The "Adhesion G-protein coupled receptor G1 (isoform a) Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about Adhesion G-protein coupled receptor G1 (isoform a) comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets